News UK postcode lottery ends for 'life-changing' cystinosis drug Patients in England with rare disease cystinosis will soon be able to access a drug that has been available in other UK nations for up to three years
Digital NHS England gets commercial NHS England is no longer the new kid on the block, taking up its role in 2013. In 2019, NHS England is a commercially savvy organisation when it comes to all things to do with medicines.
Views & Analysis How will STPs change the face of the NHS in 2017? What changes will STPs bring and what are the implications for pharma?
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.